Advanced Research Institute

New Port Richey, Florida 34655

1 studies enrolling now · 26 studies all time

What they study most

Benign Prostatic Hypertrophy, Bladder Cancer, Chronic Hepatitis C, Colonic Polyp, Endometriosis-related Pain, Eosinophilic Duodenitis, Eosinophilic Gastritis, Eosinophilic Gastroenteritis, Erectile Dysfunction, Hepatitis C, Chronic, Interstitial Cystitis, Menorrhagia

Studies at this site

• LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis — Recruiting now
• A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) — Running, not enrolling
• Pivotal Study of the CapsoCam Colon (CV-3) in Detecting Colonic Polyps, Using Colonoscopy as the Reference — Completed
• An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis — Completed
• A Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Gastroenteritis — Completed
• Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain — Completed
• Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia) — Completed
• Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer — Completed
• Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611) — Completed
• Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis — Stopped early
• Evaluation of the 2005 AMS (American Medical System) IPP (Inflatable Penile Prosthesis) — Completed
• Gilead Sustained Virologic Response (SVR) Registry — Completed
• A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response — Completed
• PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy — Completed
• Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION) — Completed
• Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon — Completed
• Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection — Completed
• A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding — Completed
• Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients — Stopped early
• Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis — Completed
• Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer — Completed
• Clinical Trial in Males With BPH (Enlarged Prostate) — Completed
• Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancer — Completed
• A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer — Completed
• Interstitial Cystitis — Completed
• ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body — Completed